Why does the mitral regurgitation murmur remain essentially unchanged during expiration, and what is the mechanism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Why the Mitral Regurgitation Murmur Remains Unchanged During Expiration

The mitral regurgitation (MR) murmur does not change significantly with expiration because it is a left-sided cardiac lesion, and left-sided heart sounds are relatively independent of respiratory variation in venous return that primarily affects right-sided cardiac chambers.

Mechanism of Respiratory Independence

The fundamental mechanism relates to how respiration affects cardiac hemodynamics:

Left-Sided vs. Right-Sided Lesions

  • Right-sided murmurs (tricuspid regurgitation, pulmonic stenosis) increase with inspiration due to increased venous return to the right heart, augmenting right ventricular stroke volume and the intensity of right-sided flow murmurs

  • Left-sided murmurs (MR, aortic stenosis, aortic regurgitation) remain essentially constant because:

    • The left heart receives blood from the pulmonary venous system, which acts as a capacitance reservoir
    • Respiratory changes in systemic venous return take several cardiac cycles to affect left heart filling
    • The pulmonary vascular bed buffers acute changes in right ventricular output

MR-Specific Hemodynamics

The MR murmur intensity is determined by:

  • The pressure gradient between the left ventricle (LV) and left atrium (LA) during systole
  • The size of the regurgitant orifice
  • The duration of regurgitation during systole

None of these factors are meaningfully altered by the respiratory cycle because:

  • LV systolic pressure remains stable with respiration
  • LA pressure is not significantly affected by intrathoracic pressure changes during normal breathing
  • The regurgitant orifice size (whether from leaflet pathology in primary MR or ventricular geometry in secondary MR) is determined by structural factors, not respiratory mechanics

Clinical Caveat

One notable exception exists: when MR coexists with pulmonic regurgitation, the pulmonic regurgitation murmur may paradoxically decrease with inspiration if significant MR is present, as inspiration reduces the volume of MR and consequently reduces pulmonary artery pressures and pulmonic regurgitant flow 1. However, this does not change the MR murmur itself—it affects the other murmur.

Practical Application

When examining a patient with a holosystolic murmur at the apex:

  • If the murmur intensity remains constant or minimally changes with respiration → suspect MR
  • If the murmur increases noticeably with inspiration → consider tricuspid regurgitation instead
  • Always correlate with radiation pattern (MR radiates to axilla; TR does not) and other physical findings

This respiratory independence is a reliable bedside finding that helps distinguish left-sided from right-sided regurgitant lesions without requiring advanced imaging.

Related Questions

Can severe mitral regurgitation cause dizziness?
What is the recommended treatment for severe mitral regurgitation?
In a 29-year-old asymptomatic man with a systolic murmur at the apex that increases with sustained handgrip and decreases with the Valsalva maneuver, what is the most likely cause?
In patients with severe mitral regurgitation, how does the long‑term outcome of percutaneous edge‑to‑edge mitral valve repair (MitraClip) compare with surgical mitral valve replacement?
Is it safe to perform laparoscopic cholecystectomy in a patient with severe mitral regurgitation, and what pre‑operative cardiac assessment and intra‑operative precautions are required?
What are examples of short-acting β‑agonists and long-acting bronchodilators?
Are inhaled corticosteroids beneficial for pulmonary fibrosis?
In a patient three days after total knee replacement who is on rivaroxaban (Xarelto) for VTE prophylaxis and now presents with mixed hematochezia and epigastric pain, without abdominal pain, nausea, vomiting, painful defecation, diarrhea, constipation, straining, or rectal lesions, what are the appropriate next diagnostic and management steps?
How important is it to start antifibrotic therapy when fibrous tissue is identified on a chest CT, and is early initiation essential?
What is the mechanism by which leukotriene C4 (LTC4) binding to an intracellular cysteinyl‑leukotriene receptor (cysLTR) induces interleukin‑4 (IL‑4) production independent of the Gq heterotrimeric protein?
How should baseline troponin T be managed and what treatment is recommended for an asymptomatic patient with chronically mildly elevated troponin T?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.